AVASTART - A multicenter, non-interventional, post-authorization study to observe in daily clinical practice the treatment duration of patients treated with Avastin (bevacizumab) in 1st line mCRC in Belgium.
Phase of Trial: Phase IV
Latest Information Update: 17 Dec 2015
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms AVASTART
- Sponsors Roche
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jun 2013 Planned End Date changed from 1 May 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 06 Jul 2012 Planned End Date changed from 1 Jan 2013 to 1 May 2013 as reported by ClinicalTrials.gov.